PAC syndrome
Conditions
Interventions
I gather 14 mL blood of a patient of the PAC syndrome, and a control, in the study purpose concerned newly.
I measure serum IL-1 beta, IL-6, TNF-alpha density by ELISA.
I isolate PBMC.
1)It is stimula
Sponsors
Hidaka Yukiko
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: object person(patient) In Kurume University Hospital collagenosis internal medicine, I intend for a patient under treatment for PAC syndrome. The one where a written agreement was provided for study entry from the person a person 20 years or older I choose one to meet all the above-mentioned standards control The one where a written agreement was provided for study entry from the person a person 20 years or older I choose one to meet all the above-mentioned standards
Exclusion criteria
Exclusion criteria: object person(patient) The one that a manager for study and a study partaker judged to be inappropriate as a study subject The pregnant woman or pregnancy with the possibility control The person who had a diagnosis of a self-inflammatory syndrome The pregnant woman or pregnancy with the possibility
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change before and after the stimulation of mRNA and the CT | — |
Secondary
| Measure | Time frame |
|---|---|
| the detection level of the ELISA including TNF-alpha, IL-6, and IL-1 beta, and more | — |
Contacts
Public ContactYukiko Hidaka
Kurume University School of Medicine
Outcome results
None listed